Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study

Abstract Background Neoadjuvant chemotherapy (NAC) is increasingly used in locally advanced gastric cancer (LAGC), but the clinical safety and efficacy are still controversial. This study aims to compare perioperative chemotherapy (PEC) with adjuvant chemotherapy (AC) for resectable LAGC. Methods Pa...

Full description

Bibliographic Details
Published in:	European Journal of Medical Research
Main Authors:	Pengfei Su, Lin Jiang, Yingjing Zhang, Tian Yu, Hongyun Huang, Moxi Chen, Can Cao, Weiming Kang, Yuqin Liu, Jianchun Yu
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Subjects:	Gastric cancer Perioperative chemotherapy Neoadjuvant chemotherapy Adjuvant chemotherapy Survival benefit
Online Access:	https://doi.org/10.1186/s40001-023-01400-3

Similar Items

The impact of delayed adjuvant chemotherapy on survival in gastric cancer patients with and without preoperative chemotherapy
by: Masataka Shimonosono, et al.
Published: (2025-07-01)

Perioperative versus adjuvant chemotherapy for resectable gastric cancer: a meta-analysis of randomized controlled trials
by: Haiya Ou, et al.
Published: (2025-03-01)

The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer
by: Jun-Bing Chen, et al.
Published: (2022-12-01)

Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II/III resectable gastric cancer (RESONANCE): a randomized, open-label, phase 3 trial
by: Xinxin Wang, et al.
Published: (2024-04-01)

Does postoperative chemotherapy improve overall survival of patients with ypT1-2N0 cancer?
by: Pengfei Su, et al.
Published: (2022-12-01)

Neoadjuvant chemotherapy for locally advanced gastric cancer in Japan: Consensus meeting at the 77th general meeting of the Japanese Society of Gastroenterological Surgery
by: Masanori Tokunaga, et al.
Published: (2023-11-01)

Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?
by: Nabil Ismaili, et al.
Published: (2011-09-01)

Timing of postoperative chemotherapy and prognosis in neoadjuvant-treated gastric cancer patients: a multicenter real-world cohort study
by: Hua-Long Zheng, et al.
Published: (2025-12-01)

Systemic adjuvant and perioperative chemotherapy following curative-intent liver metastasectomy in colorectal cancer—is it justified?
by: R.D. Peixoto, et al.
Published: (2025-09-01)

Localized stomach cancer: Perioperative or postoperative approach? A meta‐analysis of phase III studies
by: Wala Ben Kridis, et al.
Published: (2022-04-01)

Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer
by: Feizhi Lin, et al.
Published: (2024-05-01)

Impact of Postoperative Chemotherapy in Patients with Gastric/Gastroesophageal Adenocarcinoma Treated with Perioperative Chemotherapy
by: Alexej Ballhausen, et al.
Published: (2022-03-01)

Editorial: Optimal perioperative management of urothelial carcinoma
by: Ariane Holzman, et al.
Published: (2023-05-01)

High-risk bladder cancer: improving outcomes with perioperative chemotherapy
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01)

High-risk bladder cancer: improving outcomes with perioperative chemotherapy
by: Daniel Y.C. Heng, et al.
Published: (2011-12-01)

Is adjuvant chemotherapy necessary for early gastric cancer?
by: Yu Mei, et al.
Published: (2022-04-01)

Clinical Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy on Muscle-invasive Bladder Cancer
by: DENG Kangli, et al.
Published: (2019-04-01)

Perioperative Chemotherapy with FLOT Scheme in Resectable Gastric Adenocarcinoma: A Preliminary Correlation between TRG and Radiomics
by: Giovanni Maria Garbarino, et al.
Published: (2021-10-01)

Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01)

Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
by: Serhat Sekmek, et al.
Published: (2023-11-01)

Lobe‐specific analysis of perioperative chemotherapy for non‐small cell lung cancer patients
by: Xi Lei, et al.
Published: (2023-08-01)

Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study
by: Jida Chen, et al.
Published: (2023-01-01)

Chemotherapy Regimens for Non-Metastatic Conventional Appendicular Osteosarcoma: A Literature Review Based on the Outcomes
by: Joaquim Soares do Brito, et al.
Published: (2023-06-01)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
by: Jianping Guo, et al.
Published: (2023-10-01)

Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?
by: Albouzidi Abderrahmane, et al.
Published: (2011-09-01)

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
by: Yuanyuan Yu, et al.
Published: (2021-05-01)

Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
by: Guoxiu Wang, et al.
Published: (2018-05-01)

OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
by: A. D. Kaprin, et al.
Published: (2016-01-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)

Cervical Mesonephric Adenocarcinoma Treated with Neoadjuvant Chemotherapy: A Case Report and a Literature Review
by: Hiroaki Ishida, et al.
Published: (2024-11-01)

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
by: Alison Hiong, et al.
Published: (2025-09-01)

A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer
by: Freshte Foroughi, et al.
Published: (2024-12-01)

The impact of the COVID‐19 pandemic on perioperative chemotherapy for breast cancer
by: Kaede Baba, et al.
Published: (2023-06-01)

Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched studyResearch in context
by: Peter H. Cashin, et al.
Published: (2023-01-01)

Treatment Outcomes of Neoadjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma: A Propensity Score Overlap Weighting Analysis of a Multicenter Taiwanese Cohort
by: Yi-Ju Chou, et al.
Published: (2025-11-01)

Adjuvant chemotherapy may have no significant survival benefit in older patients with stage II/III gastric cancer: a multicenter retrospective study
by: Zheng-Zheng Shen, et al.
Published: (2025-05-01)

Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population‐Based Large Cohort Study
by: Lixi Li, et al.
Published: (2025-05-01)

Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle‐Invasive Bladder Cancer Treated With Radical Cystectomy
by: Shingo Hatakeyama, et al.
Published: (2025-05-01)

Evaluation of neoadjuvant immunotherapy plus chemotherapy in Chinese surgically resectable gastric cancer: a pilot study by meta-analysis
by: Hao Xu, et al.
Published: (2023-06-01)

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study
by: Jin Zhang, et al.
Published: (2021-12-01)